People news

Share this article:
ImmunoGen, a biopharma that develops targeted anticancer therapeutics, has appointed James O'Leary as VP, chief medical officer. O'Leary will lead the clinical development of ImmunoGen's product candidates. ImmunoGen has collaborated with Genentech, Sanofi-Aventis, Biogen Idec, Bayer HealthCare and Amgen.
 
Cynvec LLC, a biopharma focused on developing cancer therapies that harness the apoptotic ability of the Sindbis viral vector, has appointed Frank Stonebanks as president and CEO, effective immediately. Stonebanks has previously worked at Johnson & Johnson and led the oncology biologics business unit at Centocor.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.